Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Neuromuscular Disorders : NMD|September 11, 2002
Gene transfer studies in animals: what do they really tell us about the prospects for gene therapy in DMD?Dominic J Wells, Kim E Wells
Expert Reviews in Molecular Medicine|October 31, 2003
Immunological hurdles in the path to gene therapy for Duchenne muscular dystrophyDominic J Wells, Aurora Ferrer, Kim E Wells
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Gene delivery to dystrophic muscleKim E Wells, Jill McMahon, Helen Foster, et al.
Neuromuscular Disorders : NMD|December 7, 2002
Relocalization of neuronal nitric oxide synthase (nNOS) as a marker for complete restoration of the dystrophin associated protein complex in skeletal muscleKim E Wells, Silvia Torelli, Qi Lu, et al.
The Journal of Biological Chemistry|March 18, 2003
The neuroprotective effects of heat shock protein 27 overexpression in transgenic animals against kainate-induced seizures and hippocampal cell deathMohammed T Akbar, Anna M C Lundberg, Ke Liu, et al.
Journal of Neuromuscular Diseases|October 12, 2020
Simvastatin Treatment Does Not Ameliorate Muscle Pathophysiology in a Mouse Model for Duchenne Muscular DystrophyIngrid E C Verhaart, Ornella Cappellari, Christa L Tanganyika-de Winter, et al.
Human Molecular Genetics|November 16, 2013
The transgenic expression of LARGE exacerbates the muscle phenotype of dystroglycanopathy miceCharlotte Whitmore, Marta Fernandez-Fuente, Helen Booler, et al.
Human Molecular Genetics|May 3, 2015
How much dystrophin is enough: the physiological consequences of different levels of dystrophin in the mdx mouseCaroline Godfrey, Sofia Muses, Graham McClorey, et al.
Scientific Reports|June 27, 2015
Implications for Cardiac Function Following Rescue of the Dystrophic Diaphragm in a Mouse Model of Duchenne Muscular DystrophyCorinne A Betts, Amer F Saleh, Carolyn A Carr, et al.
Human Molecular Genetics|October 4, 2018
Cmah-dystrophin deficient mdx mice display an accelerated cardiac phenotype that is improved following peptide-PMO exon skipping treatmentCorinne A Betts, Graham McClorey, Richard Healicon, et al.
Pageof 2